After receiving a warning letter from the FDA on Aug. 16 citing “significant violations” related to two Regener-Eyes ophthalmic products, the company has implemented several improvements to address the concerns.According to the FDA, Regener-Eyes and it…
Seeing a Clearer Path to Eye Health Equity: 20/20 Onsite Mobile Vision Clinic to Conduct Free Eye Screenings at the American Diabetes Association® DMV Step Out: Walk to Stop Diabetes® on 9/21/24
WASHINGTON–(BUSINESS WIRE)–20/20 Onsite Mobile Vision Clinic to Conduct Free Eye Screenings at the American Diabetes Association® DMV Step Out: Walk to Stop Diabetes®
VIDEO: Cross-linking applied to femto-CAIRS provides easy, sterile implantation
BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Farhad Hafezi, MD, PhD, speaks about cross-linking applied to femto-CAIRS for the treatment of keratoconus.The soft segments are …
Adalimumab Tops Cyclosporine in Preventing Uveitis Relapse
Adalimumab was superior to cyclosporine in preventing uveitis relapse in patients with severe Behçet disease already on corticosteroid therapy, according to randomized, open-label trial results. Medscape Medical News
RxCell Inc. Granted U.S. Patent for iPSC-based Cell Therapy
PARK CITY, Utah–(BUSINESS WIRE)–RxCell Inc. is pleased to announce the issuance of U.S. Patent 11,946,069 entitled “Method for Generating Multiple Cellular Products from Single Pluripotent Cell Source”, a significant advancement in the field of regen…
Tough2gether Selects Bublup for Comprehensive Content Management and Community Forum
WASHINGTON–(BUSINESS WIRE)– #brainstormsummit–Tough2gether, an organization dedicated to the fight against pediatric brain tumors, has chosen Bublup, the all-in-one visual cloud platform, to manage content and facilitate community engagement. This c…